Human Stem Cell Extracts for Lung Scarring Treatment
Part of Lungs & breathing clinical trials.
This early-stage trial tests a new treatment using extracts from human umbilical cord stem cells, given by inhalation, to see if it is safe and can help patients with interstitial lung disease (a condition where lung tissue becomes scarred and stiff). The study will measure whether this approach reduces symptoms and improves how well your lungs work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with interstitial lung disease (ILD)
- A recent lung imaging scan (HRCT within 3 months) shows lung scarring or changes typical of ILD
- Your lung function test results are within acceptable ranges for the trial
- You can use a nebulizer (a machine that turns liquid medicine into mist you breathe in) without problems
- You do not need oxygen for more than 15 hours per day
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.
This study looks at how to find and treat fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) as early as possible. It may help people with this type of lung disease get better care.
This trial tests whether a special type of stem cells from umbilical cords can help people with scleroderma-related lung disease that is getting worse. You may qualify if your lung function has declined despite current treatments.
This early-phase trial tests if stem cells from donated umbilical cords can help people with interstitial lung disease. It's designed for people whose lung function is moderately reduced and who haven't tried stem cell therapy before.
This trial tests a new inhaled treatment made from placental stem cells to see if it's safe and helps slow scarring in the lungs (idiopathic pulmonary fibrosis). The treatment is breathed in through a nebulizer, similar to an asthma inhaler.
This trial tests whether umbilical cord stem cells are safe for people with mild to moderate ARDS. It aims to see if these cells can help reduce lung inflammation and improve breathing.
Hear when a new Interstitial Lung Disease (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.